Client Services
1800 800 629

File

Release Date: 01 May 2017
eMIMS Version: updates April 2017 DVD release only
File Name: FullEmimsMay17.exe
Size: 77.7 MB

Description

What's New (Full update)

The May 2017 update includes

  • Additions to the PBS:
    • Amisulpride AN (amisulpride) Southern Cross Pharma (3c)
      100 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
      200 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
      400 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
    • APO-Doxycycline (doxycycline monohydrate) Apotex (8c)
      50 mg [25]: Restricted - PBS/RPBS (NP)
      100 mg [7]: PBS/RPBS (NP)
      100 mg [7] x 4: Restricted - PBS/RPBS (NP)
      100 mg [21]: Restricted - PBS/RPBS (NP)
    • APO-Fluoxetine (fluoxetine) Apotex (3d)
      20 mg [28]: Restricted - PBS/RPBS (NP)
    • APO-Naltrexone (naltrexone hydrochloride) Apotex (20b)
      50 mg [30]: Authority - PBS/RPBS (NP)
    • APO-Tranexamic Acid (tranexamic acid) Apotex (2l)
      500 mg [100]: PBS/RPBS (NP)
    • Arianna 1 (anastrozole) Alphapharm (9e)
      1 mg [30]: Restricted - PBS/RPBS (NP)
    • Astzol (anastrozole) Juno (9e)
      1 mg [30]: Restricted - PBS/RPBS (NP)
    • Chlorsig (chloramphenicol) Aspen (14a)
      0.5% 10 mL [1]: Restricted - PBS/RPBS Optometrist (NP,MW)
    • Descovy 200/10 mg Tablets (emtricitabine; tenofovir alafenamide) Gilead (8i)
      200/10 mg [30] x 2: Section 100 - Community Access Scheme (Streamlined)
    • Descovy 200/25 mg Tablets (emtricitabine; tenofovir alafenamide) Gilead (8i)
      200/25 mg [30] x 2: Section 100 - Community Access Scheme (Streamlined)
    • Emend IV 150 mg (fosaprepitant) Merck Sharp & Dohme (9g)
      150 mg [1]: Authority (Streamlined) - PBS/RPBS (NP)
    • Furosemide AN (furosemide (frusemide)) Amneal (2c)
      20 mg [100]: PBS/RPBS (NP)
      40 mg [100]: PBS/RPBS (NP)
    • Genvoya (multiple actives) Gilead (8i)
      [30] x 2: Section 100 - Community Access Scheme (Streamlined)
    • Kalydeco (ivacaftor) Vertex (11e)
      50 mg [56]: Section 100 - Highly Specialised Drugs Private Hospitals
      50 mg [56]: Section 100 - Highly Specialised Drugs Public Hospitals
      75 mg [56]: Section 100 - Highly Specialised Drugs Private Hospitals
      75 mg [56]: Section 100 - Highly Specialised Drugs Public Hospitals
    • Keyo (multiple actives) Vitaflo (19b)
      100 g [48] x 3: Restricted - PBS/RPBS (NP)
    • Nevirapine XR APOTEX (nevirapine) Apotex (8i)
      400 mg [30] x 2: Section 100 - Community Access Scheme (Streamlined)
    • Nutrini Peptisorb Energy (multiple actives) Nutricia (19b)
      500 mL [8] x 10: Restricted - PBS/RPBS (NP)
    • Odefsey (multiple actives) Gilead (8i)
      [30] x 2: Section 100 - Community Access Scheme (Streamlined)
    • Ofev (nintedanib) Boehringer Ingelheim (9f)
      100 mg [60]: Authority - PBS/RPBS
      150 mg [60]: Authority - PBS/RPBS
    • Phenobarb (phenobarbital (phenobarbitone)) Arrow (3g)
      30 mg [200]: Restricted - PBS/RPBS (NP)
    • Rosuvastatin Generichealth (rosuvastatin) Dr Reddy's (2f)
      5 mg [30]: Restricted - PBS/RPBS (NP)
      10 mg [30]: Restricted - PBS/RPBS (NP)
      20 mg [30]: Restricted - PBS/RPBS (NP)
      40 mg [30]: Restricted - PBS/RPBS (NP)
    • Targin 60/30 mg Tablets (oxycodone hydrochloride; naloxone hydrochloride) Mundipharma (4a)
      [28]: Restricted - PBS/RPBS (NP)
    • Targin 80/40 mg Tablets (oxycodone hydrochloride; naloxone hydrochloride) Mundipharma (4a)
      [28]: Restricted - PBS/RPBS (NP)
    • Temolide (temozolomide) Juno (9a)
      5 mg [5] x 3: Restricted - PBS/RPBS
      20 mg [5] x 3: Restricted - PBS/RPBS
      100 mg [5] x 3: Restricted - PBS/RPBS
      180 mg [5] x 3: Restricted - PBS/RPBS
      140 mg [5] x 3: Restricted - PBS/RPBS
      250 mg [5]: PBS/RPBS
    • Zinbryta (daclizumab) Biogen Australia (10c)
      150 mg/mL 1 mL (prefilled pen) [1]: Authority - PBS/RPBS
  • Restriction changes:
    • Akynzeo (netupitant; palonosetron) Mundipharma (9g)
      300 mg/500 mcg [1]: Authority (Streamlined) - PBS/RPBS (NP)
    • Aubagio (teriflunomide) Sanofi-Aventis (10c)
      14 mg [28]: Authority - PBS/RPBS
    • Avonex (interferon beta-1a) Biogen Australia (10c)
      6 x 106 IU/0.5 mL (equiv. 30 mcg) [4]: Authority (Streamlined) - PBS/RPBS
    • Betaferon (interferon beta-1b) Bayer (10c)
      8 x 106 IU (+ solv.) [15]: Authority (Streamlined) - PBS/RPBS
    • Calcipotriol/Betamethasone Sandoz 50/500 (calcipotriol; betamethasone dipropionate) Sandoz (15b)
      30 g [1]: Restricted - PBS/RPBS (NP)
    • Carbamazepine Sandoz (carbamazepine) Sandoz (3g)
      200 mg [100] x 2: PBS/RPBS (NP)
    • Champix (varenicline) Pfizer (20b)
      [1]: Authority (Streamlined) - PBS/RPBS (NP)
      1 mg [56] x 2: Authority (Streamlined) - PBS/RPBS (NP)
    • Copaxone Prefilled Syringe (glatiramer acetate) Teva (10c)
      20 mg/mL (prefilled syringe) [28]: Authority (Streamlined) - PBS/RPBS
      40 mg/mL (prefilled syringe) [12]: Authority (Streamlined) - PBS/RPBS
    • Daivobet 50/500 Gel (calcipotriol; betamethasone dipropionate) Leo (15b)
      30 g [1]: Restricted - PBS/RPBS (NP)
      60 g [1]: Authority (Streamlined) - PBS/RPBS (NP)
    • Daivobet 50/500 Ointment (calcipotriol; betamethasone dipropionate) Leo (15b)
      30 g [1]: Restricted - PBS/RPBS (NP)
    • Duodopa (levodopa; carbidopa) AbbVie (3f)
      100 mL [7] x 8: Section 100 - Highly Specialised Drugs Private Hospitals
      100 mL [7] x 8: Section 100 - Highly Specialised Drugs Public Hospitals (Streamlined)
    • Gilenya (fingolimod) Novartis (10c)
      0.5 mg [28]: Authority - PBS/RPBS
    • Kalydeco (ivacaftor) Vertex (11e)
      150 mg [56]: Section 100 - Highly Specialised Drugs Private Hospitals
      150 mg [56]: Section 100 - Highly Specialised Drugs Public Hospitals
    • Lemtrada (alemtuzumab) Sanofi-Aventis (10c)
      12 mg/1.2 mL [1] x 5: Section 100 - Highly Specialised Drugs Private Hospitals
      12 mg/1.2 mL [1] x 5: Section 100 - Highly Specialised Drugs Public Hospitals (Streamlined)
    • Miacalcic (calcitonin salmon (salcatonin)) Novartis (6g)
      100 IU/mL [5] x 3: Restricted - PBS/RPBS (NP)
    • Nicabate P (nicotine) GlaxoSmithKline Consumer (20b)
      21 mg/24 hours [28]: Restricted - PBS/RPBS (NP)
    • Nicorette 16hr Invisipatch (nicotine) J&J Pacific (20b)
      25 mg/16 hours (22.5 cm2) [28]: Restricted - PBS/RPBS (NP)
    • Nicotinell Patch (nicotine) Perrigo Australia (20b)
      7 mg/24 hours [28]: Restricted - PBS/RPBS (NP)
      14 mg/24 hours [28]: Restricted - PBS/RPBS (NP)
      21 mg/24 hours [28]: Restricted - PBS/RPBS (NP)
    • Orencia (abatacept) Bristol-Myers Squibb (10c)
      125 mg/mL 1 mL [4]: Authority - PBS/RPBS
    • Orencia ClickJect (abatacept) Bristol-Myers Squibb (10c)
      125 mg/mL 1 mL (prefilled autoinjector) [4]: Authority - PBS/RPBS
    • Plegridy (peginterferon beta-1a) Biogen Australia (10c)
      125 mcg/0.5 mL [2]: Authority (Streamlined) - PBS/RPBS
    • Rebif multidose cartridge (interferon beta-1a) Merck Serono (10c)
      132 mcg/1.5 mL [4]: Authority (Streamlined) - PBS/RPBS
    • Rebif prefilled syringe (interferon beta-1a) Merck Serono (10c)
      44 mcg/0.5 mL [12]: Authority (Streamlined) - PBS/RPBS
    • Rebif single use autoinjector (interferon beta-1a) Merck Serono (10c)
      44 mcg/0.5 mL [12]: Authority (Streamlined) - PBS/RPBS
    • Tecfidera (dimethyl fumarate) Biogen Australia (10c)
      120 mg [14]: Authority - PBS/RPBS
      240 mg [56]: Authority - PBS/RPBS
    • Tegretol (carbamazepine) Novartis (3g)
      200 mg [100] x 2: PBS/RPBS (NP)
    • Tysabri (natalizumab) Biogen Australia (10c)
      300 mg/15 mL [1]: Section 100 - Highly Specialised Drugs Private Hospitals
      300 mg/15 mL [1]: Section 100 - Highly Specialised Drugs Public Hospitals (Streamlined)
    • Zyban Sustained Release (Tablets) (bupropion hydrochloride) Aspen (20b)
      150 mg [30]: Authority (Streamlined) - PBS/RPBS (NP)
  • Restriction Level Changes - Authority-required to Streamlined:
    • Champix (varenicline) Pfizer (20b)
      1 mg [56] x 2: Authority (Streamlined) - PBS/RPBS (NP)
  • Maximum Quantity changes:
    • Fraxiparine (nadroparin calcium) Aspen (2k)
      1900 IU/0.2 mL [2] x 10: Restricted - PBS/RPBS (NP)
      2850 IU/0.3 mL [2] x 10: Restricted - PBS/RPBS (NP)
      3800 IU/0.4 mL [2] x 10: Restricted - PBS/RPBS (NP)
      5700 IU/0.6 mL [2] x 10: Restricted - PBS/RPBS (NP)
      7600 IU/0.8 mL [2] x 10: Restricted - PBS/RPBS (NP)
      9500 IU/mL 1 mL [2] x 10: Restricted - PBS/RPBS (NP)
    • Fraxiparine Forte (nadroparin calcium) Aspen (2k)
      11,400 IU/0.6 mL [2] x 5: PBS/RPBS (NP)
      15,200 IU/0.8 mL [2] x 5: PBS/RPBS (NP)
      19,000 IU/mL [2] x 5: PBS/RPBS (NP)
  • Bioequivalence Indicator Additions :
    • Cyklokapron (tranexamic acid) Pfizer (2l)
      500 mg [100]: PBS/RPBS (NP)
    • Viramune XR Tablets (nevirapine) Boehringer Ingelheim (8i)
      400 mg [30] x 2: Section 100 - Community Access Scheme (Streamlined)
  • the latest MIMS Medicine Information
    • Over 175 updates or additions to the MIMS listings
    New listings include:
    • Amisulpride AN (amisulpride) Southern Cross Pharma (3c)
    • APO-Doxycycline (doxycycline monohydrate) Apotex (8c)
    • APO-Fluoxetine (fluoxetine) Apotex (3d)
    • APO-Naltrexone (naltrexone hydrochloride) Apotex (20b)
    • APO-Tranexamic Acid (tranexamic acid) Apotex (2l)
    • Arianna 1 (anastrozole) Alphapharm (9e)
    • Astzol (anastrozole) Juno (9e)
    • Belkyra (deoxycholic acid) Allergan (15k)
    • Bio-Logical Vitamin A solution (retinyl palmitate) Biological Therapies (21d)
    • Eagle CytoPro Repair (multiple actives) Integria (Eagle) (1e)
    • Epiduo Forte (adapalene; benzoyl peroxide) Galderma (15c)
    • Grazax (phleum pratense pollen allergen extract) Seqirus (12b)
    • Keyo (multiple actives) Vitaflo (19b)
    • Nevirapine XR APOTEX (nevirapine) Apotex (8i)
    • Nutrini Peptisorb Energy (multiple actives) Nutricia (19b)
    • Olmesartan/Amlodipine HCT-MYL (multiple actives) Merck Sharp & Dohme (2a)
    • Phenobarb (phenobarbital (phenobarbitone)) Arrow (3g)
    • Ranital Forte (ranitidine) Sandoz (1a)
    • Rosuvastatin Generichealth (rosuvastatin) Dr Reddy's (2f)
    • Stivarga (regorafenib) Bayer (9f)
    • Temolide (temozolomide) Juno (9a)
  • the latest MIMS DrugAlert data
  • the latest CMIs
    • Over 180 updates or additions to the collection